GomSpace reports continued profitable growth in Q3 and narrows full year guidance

GomSpace reported Q3 2026 revenue up 17% to 130,395 T.SEK and EBITDA up 68% to 18,642 T.SEK, a 14% EBITDA margin; order intake rose 104% to 119,688 T.SEK. EBIT increased to 8,592 T.SEK, while free cash flow was -41,658 T.SEK and earnings per share remained 0.08 SEK. The company set 2030 targets of SEK 1.6 billion in revenue and an EBITDA margin above 20%, and narrowed full-year 2026 guidance; year-to-date order intake was up 1%.

Analysis

The better signal is Q3 operating leverage; the weaker one is demand visibility. A 104% quarterly order-intake increase alongside only 1% year-to-date growth points to lumpy bookings, not yet a demonstrated step-change in the run rate. The key question is whether those bookings convert into funded backlog and revenue without worsening working capital. Negative free cash flow remains a counterweight to the EBITDA improvement; it makes cash conversion and liquidity more important than the 2030 margin aspiration.

Near term, the narrowed 2026 guidance could drive the next repricing, but its direction and range are not supplied, so the headline alone cannot establish whether expectations are reset up or down. Over 1–3 months, track guidance, backlog conversion, and cash flow. Over 6–18 months, sustained delivery would support the case that scale can lift margins; failure to convert orders or persistent cash outflow would undermine it. The 2030 targets are management goals, not evidence of an established earnings trajectory. A plausible competitive spillover is stronger order competition for smaller satellite-system providers such as AAC Clyde Space, but the article gives no evidence of direct customer or supply-chain exposure.

Key Decisions for Investors

• Do not chase GOMX solely on the Q3 order-intake jump. First verify the exact revised 2026 guidance range, order cancellations or funding conditions, and the composition and delivery timing of backlog.
• Treat GOMX as a watch-list long rather than a confirmed catalyst trade: consider entry only if the next reporting point shows revenue conversion and improving cash generation alongside bookings. Falsifier: order intake remains weak on a year-to-date basis while free cash flow deteriorates.
• Monitor cash conversion separately from EBITDA. Persistent negative free cash flow could cap valuation or raise balance-sheet risk even if reported margins improve; verify liquidity and working-capital drivers before sizing exposure.
• For a relative-value screen, compare GOMX with AAC Clyde Space on new awards, backlog quality, and cash conversion; do not infer that this quarter’s bookings directly displace competitors.